Transitional cell carcinoma, often referred to as TCC, is a particularly menacing form of malignant tumor that afflicts the urinary bladder. This tumor, also known as urothelial carcinoma, tends to originate in the lower neck of the bladder in dogs, an area where surgical removal is often impractical. This location leads to partial or complete obstruction of urination. In over half of diagnosed TCC cases in dogs, the urethra (the tube carrying urine outside the body) is affected, and male animals might see involvement of the prostate gland. In contrast, TCC in cats varies in its location within the bladder, making it challenging to predict whether a mass is a benign polyp or a malignant tumor based solely on location. The telltale signs noticed by owners include bloody urine and strained urination, regardless of whether the patient is a dog or a cat. However, these symptoms are also common with bladder infections, which are often present alongside the tumor, making diagnosis a bit tricky due to the similarities in symptoms.
The "Transitional" Epithelial Cells
Transitional cell carcinoma is a tumor that originates from transitional epithelial cells, which line the urinary bladder. These specialized cells are tasked with shielding the body from the corrosive urine within the bladder while also maintaining this barrier during the bladder's expansion and contraction. These cells adapt their shape to accommodate volume changes in the bladder. This type of carcinoma emerges from the transitional epithelial cell lining.
While bladder tumors aren't very common in pets, over half, and possibly up to 70%, of those diagnosed are transitional cell carcinomas.
What Sparks This Tumor?
Similar to many cancers, the exact causes of TCC aren't well-defined. It's believed that repeated exposure to carcinogens in the urine plays a crucial role. For instance, chemotherapy with cyclophosphamide is one identified cause. Additionally, the disease is more prevalent in female dogs, possibly because they engage in less urine marking, which could result in prolonged storage of urinary toxins. Interestingly, in cats, males face an increased risk compared to females. Urban living and obesity have also been linked to higher TCC risk. Certain breeds, such as Shetland sheepdogs, West Highland White terriers, Beagles, and Scottish terriers, appear predisposed. However, specific triggers remain largely unknown.
Recent research demonstrated that exposure to lawns treated with phenoxy herbicides increased the risk of TCC in Scottish terriers. Another study suggested that feeding yellow/orange or green-leafy vegetables at least three times a week could potentially reduce the risk of TCC in Scottish terriers.
The average age of diagnosis is 11 years in dogs and 15 years in cats.
Pinpointing the Tumor: Testing and Diagnosis
Bloody urine and straining during urination might stem from various conditions other than cancer. Severe bladder infections, bladder stones, or feline lower urinary tract disease are more common causes, and they must be systematically ruled out before confirming a diagnosis.
Step One: Urinalysis and Culture
Urinalysis and culture are fundamental tests in diagnosing bladder infection. A urinalysis involves chemical and microscopic examination of urine, while a culture identifies bacteria present and determines effective antibiotics.
Around 30% of TCC cases result in tumor cells being shed into the urine, which can be detected through urinalysis.
If a bladder infection is confirmed, treating it with the appropriate antibiotic could alleviate the symptoms. However, if symptoms persist or recur after treatment, further investigation is needed.
Step Two: Imaging
If no infection is found, or if symptoms persist despite treatment, imaging such as radiographs or ultrasound is the next step. Ultrasound can visualize soft tissue structures inside the bladder, unlike radiographs, which can't detect tumors. Radiography is particularly useful for ruling out bladder stones.
Step Three: Advanced Imaging Techniques
If symptoms remain unresolved, more specific imaging methods are employed to inspect the inside of the urinary bladder. Techniques include contrast radiography and cystoscopy, which uses a small camera to visualize and potentially biopsy the bladder wall.
Step Four: Confirmation
A confirmed diagnosis can sometimes be reached through the identification of a growth within the bladder, even with inconclusive tissue samples.
Managing Transitional Cell Carcinoma: Prognosis and Treatment
Determining prognosis and available treatments is crucial once a pet is diagnosed with TCC. Prognosis depends on the stage of the disease, including whether the tumor is invading other local organs or spreading to lymph nodes and other areas.
Surgical Options
- Partial Removal of the Bladder (Palliative Treatment): If the tumor is small and detected early, partial removal of the bladder might be attempted. However, recurrence is common.
- Complete Removal of the Bladder (Definitive Treatment): Complete removal of the bladder is invasive and results in urinary incontinence, as urine passes through the colon or an alternative channel.
- Permanent Urinary Catheter (Palliative Treatment): A permanently placed urinary catheter can ease urination but predisposes the pet to bladder infections.
- Urethral Stenting (Palliative Treatment): A metal stent is inserted into the urethra to allow urine passage, but incontinence can be a problem.
- Laser Ablation with Chemotherapy (Palliative Treatment): Laser ablation followed by chemotherapy has shown promise in symptom relief, though it's more suitable for female dogs.
Medication (Chemotherapy)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Piroxicam and other NSAIDs show anti-inflammatory and anti-tumor activity. NSAIDs can be used alone or in combination with other treatments.
- Mitoxantrone: A combination of mitoxantrone and piroxicam has shown response rates and longer survival times in some patients.
- Carboplatin: Carboplatin combined with piroxicam offers a higher remission rate, but side effects can be more pronounced.
- Gemcitabine: Gemcitabine combined with piroxicam has yielded promising results in terms of survival time and disease control.
Radiation Therapy
Advanced technology enables better-targeted radiation therapy, though specialized facilities are needed to deliver this treatment.
Transitional cell carcinoma poses a serious threat to pets' well-being. Prompt diagnosis, prognosis assessment, and effective treatments are essential to improve their quality of life and extend their survival. Collaborating closely with veterinarians and exploring the available options can make a significant difference in managing this challenging condition. Remember, your dedication and informed choices play a pivotal role in your pet's journey toward a better life.
Don't have a vet in your area yet? We can help you find a local veterinarian.
If you have more questions, the GeniusVets Telehealth platform will give you unlimited access to text and/or video calls with board-certified veterinarians! To learn more click here.